Anthrax Vaccine Approval Expanded

TUESDAY, Nov. 24, 2015 — U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure, the agency said in a media release.
The vaccine was first…
Source: Topamax